|
Seykora, J; Elder, D (1996) Dysplastic nevi and other risk markers for melanoma. Semin Oncol 23:682-7
|
|
Elder, D E; Van Belle, P; Elenitsas, R et al. (1996) Neoplastic progression and prognosis in melanoma. Semin Cutan Med Surg 15:336-48
|
|
Elder, D E (1995) Skin cancer. Melanoma and other specific nonmelanoma skin cancers. Cancer 75:245-56
|
|
Clark Jr, W H (1995) The nature of cancer: morphogenesis and progressive (self)-disorganization in neoplastic development and progression. Acta Oncol 34:3-21
|
|
Clark, W H; Goldstein, A M; Tucker, M A (1995) Prospectives for cutaneous malignant melanoma. Considerations of the precursor state and heritability. Br Med Bull 51:717-46
|
|
Clark Jr, W H; Tucker, M A; Goldstein, A M (1995) Parenchymal-stromal interactions in neoplasia. Theoretical considerations and observations in melanocytic neoplasia. Acta Oncol 34:749-57
|
|
Carey Jr, W P; Thompson, C J; Synnestvedt, M et al. (1994) Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer 74:3118-25
|
|
Isshiki, K; Seng, B A; Elder, D E et al. (1994) Chromosome 9 deletion in sporadic and familial melanomas in vivo. Oncogene 9:1649-53
|
|
Clark Jr, W H (1994) From the melanocyte to melanoma to tumor biology. Adv Cancer Res 65:113-40
|
|
Lazzaro, B; Elder, D E; Rebers, A et al. (1993) Immunophenotyping of compound and spitz nevi and vertical growth-phase melanomas using a panel of monoclonal antibodies reactive in paraffin sections. J Invest Dermatol 100:313S-317S
|
Showing the most recent 10 out of 42 publications
